250 related articles for article (PubMed ID: 28718694)
21. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
Ryder CB; Oduro KA; Moore EM
Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
[TBL] [Abstract][Full Text] [Related]
23. Composite Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia and Follicular Lymphoma: A Clinicopathological Study of Six Cases.
Jelloul FZ; Chen QH; Yang T; Haghi N; Brody J; Zhang X; Sheikh-Fayyaz S
Int J Surg Pathol; 2018 Apr; 26(2):135-144. PubMed ID: 29069998
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience.
Tsimberidou AM; O'Brien S; Kantarjian HM; Koller C; Hagemeister FB; Fayad L; Lerner S; Bueso-Ramos CE; Keating MJ
Cancer; 2006 Sep; 107(6):1294-302. PubMed ID: 16902984
[TBL] [Abstract][Full Text] [Related]
26. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
27. Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Shanafelt TD; Kay NE; Rabe KG; Inwards DJ; Zent CS; Leis JF; Schwager SM; Thompson CA; Bowen DA; Witzig TE; Slager SL; Call TG
Cancer; 2012 Apr; 118(7):1827-37. PubMed ID: 22009554
[TBL] [Abstract][Full Text] [Related]
28. Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
Mauro FR; Galieni P; Tedeschi A; Laurenti L; Del Poeta G; Reda G; Motta M; Gozzetti A; Murru R; Caputo MD; Campanelli M; Frustaci AM; Innocenti I; Raponi S; Guarini A; Morabito F; FoĆ R; Gentile M
Am J Hematol; 2017 Jun; 92(6):529-535. PubMed ID: 28295527
[TBL] [Abstract][Full Text] [Related]
29. Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.
Tees MT; Flinn IW
Expert Rev Hematol; 2017 Feb; 10(2):137-146. PubMed ID: 27936980
[TBL] [Abstract][Full Text] [Related]
30. Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome.
Trimech M; Letourneau A; Missiaglia E; De Prijck B; Nagy-Hulliger M; Somja J; Vivario M; Gaulard P; Lambert F; Bisig B; de Leval L
Am J Surg Pathol; 2021 Jun; 45(6):773-786. PubMed ID: 33739791
[TBL] [Abstract][Full Text] [Related]
31. Dietary factors and risk of chronic lymphocytic leukemia and small lymphocytic lymphoma: a pooled analysis of two prospective studies.
Tsai HT; Cross AJ; Graubard BI; Oken M; Schatzkin A; Caporaso NE
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2680-4. PubMed ID: 20929883
[TBL] [Abstract][Full Text] [Related]
32. Evaluating population-level outcomes in Chronic Lymphocytic leukemia in the era of novel therapies using the SEER registry.
Muthiah C; Narra R; Atallah E; Juan W; Szabo A; Guru Murthy GS
Leuk Res; 2024 May; 140():107496. PubMed ID: 38547577
[TBL] [Abstract][Full Text] [Related]
33. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.
Dores GM; Anderson WF; Curtis RE; Landgren O; Ostroumova E; Bluhm EC; Rabkin CS; Devesa SS; Linet MS
Br J Haematol; 2007 Dec; 139(5):809-19. PubMed ID: 17941952
[TBL] [Abstract][Full Text] [Related]
34. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
[TBL] [Abstract][Full Text] [Related]
35. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
[TBL] [Abstract][Full Text] [Related]
36. Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Lei MM; Sorial MN; Lou U; Yu M; Medrano A; Ford J; Nemec RA; Abramson JS; Soumerai JD
Leuk Lymphoma; 2024 May; 65(5):653-659. PubMed ID: 38293753
[TBL] [Abstract][Full Text] [Related]
37. The pathological features of leukemic cells infiltrating the renal interstitium in chronic lymphocytic leukemia/small lymphocytic lymphoma from a large single Chinese center.
Wang H; Yu X; Zhang X; Wang S; Zhao M
Diagn Pathol; 2021 Jul; 16(1):59. PubMed ID: 34218814
[TBL] [Abstract][Full Text] [Related]
38. Peripheral T-cell lymphomas with cytotoxic phenotype in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Boyer DF; Lindeman NI; Harris NL; Ferry JA
Am J Surg Pathol; 2014 Feb; 38(2):279-88. PubMed ID: 24418862
[TBL] [Abstract][Full Text] [Related]
39. Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Litchy S; Barton JH; Houston GA; Hermann RC; Bradof JE; Greco FA;
J Clin Oncol; 2003 May; 21(9):1746-51. PubMed ID: 12721250
[TBL] [Abstract][Full Text] [Related]
40. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]